|
1. Ståhle L, Ungerstedt U. Effects of neuroleptic drugs on the inhibition of exploratory behaviour induced by a low dose of apomorphine: implications for the identity of dopamine receptors. Pharmacol Biochem Behav. 1986 Aug; 25(2): 473-80. 2. Bowles TM, Levin GM. Aripiprazole: a new atypical antipsychotic drug. Ann Pharmacother. 2003 May; 37(5): 687-94. doi:10.1345/aph.1C297 3. Jensen RJ. Effects of antipsychotic drugs haloperidol and clozapine on visual responses of retinal Ganglion cells in a rat model of retinitis pigmentosa. J Ocul Pharmacol Ther. 2016 Dec; 32(10): 685-90. doi:10.1089/jop.2016.0102 4. Waddington JL, Gamble SJ. Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues. Psychopharmacology (Berl). 1980; 71(1): 75-7. 5. He K, Cai L, Shi Q, Liu H, Woolf TF. Inhibition of MDR3 activity in human hepatocytes by drugs associated with liver injury. Chem Res Toxicol. 2015 Oct; 28(10): 1987-90. doi:10.1021/acs.chemrestox.5b00201 6. Van Putten T, Marder SR, Mintz J, Poland RE. Haloperidol plasma levels and clinical response: a therapeutic window relationship. Am J Psychiatry. 1992 Apr; 149(4): 500-5. 7. Shinoda Y, Tagashira H, Bhuiyan MS, Hasegawa H, Kanai H, Fukunaga K. Haloperidol aggravates transverse aortic constriction-induced heart failure via mitochondrial dysfunction. J Pharmacol Sci. 2016 Jul; 131(3): 172-83. doi:10.1016/j.jphs.2016.05.012 8. Zhang XR, Zhang ZJ, Jenkins TA, Cheng WR, Reynolds GP. The dose-dependent effect of chronic administration of haloperidol, risperidone, and quetiapine on sexual behavior in the male rat. J Sex Med. 2011 Dec; 8(12): 3345-53. doi:10.1111/j.1743-6109.2010.01740.x 9. Halici Z, Dursun H, Keles ON, Odaci E, Suleyman H, Aydin N, et al. Effect of chronic treatment of haloperidol on the rat liver: a stereological and histopathological study. Naunyn Schmiedebergs Arch Pharmacol. 2009 Mar; 379(3): 253-61. doi:10.1007/s00210-008-0362-z 10. Meganathan M, Madhana Gopal K, Sasikala P, Mohan J, Gowdhaman N, Balamurugan K, et al. Evaluation of hepatoprotective effect of omega 3-Fatty acid against paracetamol induced liver injury in albino rats. Global Journal of Pharmacology. 2011; 5(1): 50-53. 11. Hussein RRS, Soliman RH, Abdelhaleem Ali AM, Tawfeik MH, Abdelrahim MEA. Effect of antiepileptic drugs on liver enzymes. Beni-Suef University Journal of Basic and Applied Sciences. 2013; 2(1): 14-19. https://doi.org/10.1016/j.bjbas.2013.09.002 12. Harper HA, Redwel UM, Mayes PA. Review of physiological chemistry. 17th ed. California: Long Medical Publication. 2009; p: 7. 13. Kaplowitz N. Drug-induced liver disorders: implications for drug development and regulation. Drug Saf. 2001;24(7):483-90. 14. Bogin JF. Animal Anatomy and physiology. 2nd ed. Virginia: Reston Publishing. 2009; pp: 154-56. 15. Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010 Feb; 38(2): 419-27. doi:10.1097/CCM.0b013e3181b9e302 16. Baratta JL, Ngo A, Lopez B, Kasabwalla N, Longmuir KJ, Robertson RT. Cellular organization of normal mouse liver: a histological, quantitative immunocytochemical, and fine structural analysis. Histochem Cell Biol. 2009 Jun; 131(6): 713-26. doi:10.1007/s00418-009-0577-1 17. Raeder MB, Fernø J, Vik-Mo AO, Steen VM. SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects? Mol Cell Biochem. 2006 Sep; 289(1-2): 167-73. doi:10.1007/s11010-006-9160-4 18. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995 Jul; 269(5223): 540-43. 19. Holt MP, Cynthia JU. Mechanisms of drug-induced liver injury. AAPS J. 2006; 8(1): E48-E54. doi:10.1208/aapsj080106 20. Manceaux P, Constant E, Zdanowicz N, Jacques D, Reynaert C. Management of marked liver enzyme increase during olanzapine treatment: a case report and review of the literature. Psychiatr Danub. 2011 Sep; 23 Suppl 1: S15-7. 21. Berk P, Korenblat K. Approach to the patient with jaundice or abnormall liver tests. In: Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia: Sunders Company. 2011; p: 149. 22. Billiard M, Blood DC, Radostits OM. Veterinary medicine. 7th ed. London: Baillier and Tindal. 2009; pp: 228-98. 23. Gill M, Sanyal SN, Sareen ML. Interaction of H2-receptor antagonists, cimetidine and ranitidine with microsomal drug metabolizing and other systems in liver. Indian J Exp Biol. 1991 Sep; 29(9): 852-56. 24. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harpers Biochemestry. 23rd ed. California: Appleton and Lange. 2010; pp: 145-251, 345-51. 25. Lauressergues E, Bert E, Duriez P, Hum D, Majd Z, Staels B, Cussac D. Does endoplasmic reticulum stress participate in APD-induced hepatic metabolic dysregulation? Neuropharmacology. 2012 Feb; 62(2): 784-96. doi:10.1016/j.neuropharm.2011.08.048 26. Mesure G, Bayle F, Vanelle JM, Olié JP, Lôo H. [Cytolytic hepatitis during treatment with phenothiazines: apropos of a case]. Encephale. 1996 Sep-Oct; 22(5): 388-90. [Article in French] 27. Arana GW, Hyman SE, Rosen Baum JF. Hand book of psychiatric drug therapy. 4th ed. Philadelphia: Lippincott Williams & Wilkins. 2010. pp: 1-20. 28. Giboney PT. Mildly elevated liver transaminase levels in the asymptomatic patient. Am Fam Physician. 2005 Mar; 71(6): 1105-10.
|
